Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Publications

Asparagine availability controls germinal center B cell homeostasis.

Yazicioglu YF. et al, (2024), Science immunology, 9

Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients.

Colton H. et al, (2024), British journal of haematology

COVID-19 vaccines are effective at preventing symptomatic and severe infection among healthcare workers: A clinical review

Galgut O. et al, (2024), Vaccine: X, 20

Obesity differs from diabetes mellitus in antibody and T-cell responses post-COVID-19 recovery

Ali M. et al, (2024), Clinical and Experimental Immunology, 218, 78 - 92

Starvation and infection: The role of sickness-associated anorexia in metabolic adaptation during acute infection

Jindal J. et al, (2024), Metabolism, 156035 - 156035

Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.

Suwarti S. et al, (2024), BMC infectious diseases, 24

Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike.

Duyvesteyn HME. et al, (2024), Structure (London, England : 1993)

Dysregulated immunologic landscape of early host response in melioidosis.

Rongkard P. et al, (2024), JCI insight

Using matrix assisted laser desorption ionisation mass spectrometry combined with machine learning for vaccine authenticity screening.

Clarke R. et al, (2024), NPJ vaccines, 9

Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: a prospective observational study in Vietnam.

Thanh TT. et al, (2024), International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Diabetes and risk of hospitalisation due to infection in northeastern Thailand: Retrospective cohort study using population-based healthcare service data.

Peerawaranun P. et al, (2024), Diabetic medicine : a journal of the British Diabetic Association

Diabetes mellitus is associated with a shared hyper-inflammatory immune response in melioidosis and tuberculosis patients: an observational case-control study

Rongkard P. et al, (2024)

Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy.

Lim YJ. et al, (2024), British journal of haematology

Implications of suboptimal measles immunity in UK health-care workers.

Ho A. et al, (2024), Lancet (London, England)

A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity.

Liu C. et al, (2024), Cell reports. Medicine

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

Schumacher AE. et al, (2024), The Lancet, 403, 1989 - 2056

Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.

Goodyear CS. et al, (2024), The Lancet. Rheumatology

Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study

Jackson S. et al, (2024), The Lancet Microbe

Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium

Nhu LNT. et al, (2024), Wellcome Open Research, 9, 181 - 181

Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection.

Liu C. et al, (2024), Nature communications, 15

Load More